Repository logo
 

Serum 25-Hydroxyvitamin D Concentrations and Ischemic Stroke and Its Subtypes.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Larsson, Susanna C 
Mishra, Aniket 
Howson, Joanna MM 
Michaëlsson, Karl 

Abstract

Background and Purpose- Observational studies have reported increased risk of ischemic stroke among individuals with low serum 25-hydroxyvitamin D (S-25OHD) concentrations but uncertainty remains about the causality of this association. We sought to determine whether S-25OHD concentrations are causally associated with ischemic stroke and its subtypes using Mendelian randomization. Methods- We used summary-level data for ischemic stroke (34 217 cases and 404 630 noncases) from the MEGASTROKE consortium. As instruments, we used 6 single nucleotide polymorphisms, explaining 7.5% of the variance in S-25OHD, previously identified to be associated with S-25OHD concentrations in the Study of Underlying Genetic Determinants of Vitamin D and Highly Related Traits consortium (n=79 366). The analyses were conducted using the inverse-variance-weighted method and complemented with the weighted median, heterogeneity-penalized, and Mendelian randomization-Egger approaches. Results- Genetically higher S-25OHD concentration was not associated with ischemic stroke. The odds ratios (95% CI) per genetically predicted 1-SD (≈18 nmol/L) increase in S-25OHD concentrations, based on all 6 single nucleotide polymorphisms, were 1.01 (0.94-1.08; P=0.84) for all ischemic stroke, 0.94 (0.80-1.11; P=0.49) for large artery stroke, 0.95 (0.82-1.11; P=0.55) for small vessel stroke, and 1.02 (0.90-1.16; P=0.74) for cardioembolic stroke. The results were similar in sensitivity analyses. Conclusions- These findings provide no support that higher S-25OHD concentrations are causally associated with any ischemic stroke subtype. Thus, vitamin D supplementation will unlikely reduce the risk of ischemic stroke in the general population.

Description

Keywords

25-hydroxyvitamin D, polymorphisms, single nucleotide, random allocation, stroke, vitamin D

Journal Title

Stroke

Conference Name

Journal ISSN

0039-2499
1524-4628

Volume Title

49

Publisher

American Heart Association
Sponsorship
British Heart Foundation (None)
This work was supported by the Swedish Research Council for Health, Working Life and Welfare and the Swedish Brian Foundation. H.S. Markus is supported by a National Institute for Health Research Senior Investigator award, and his and Dr Traylor’s work is supported by infrastructural support from the Cambridge University Hospitals Trust National Institute for Health Research Biomedical Research Centre.